Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe
- PMID: 27685538
- DOI: 10.1164/rccm.201606-1097LE
Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe
Comment in
-
Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.Am J Respir Crit Care Med. 2017 Dec 1;196(11):1488-1489. doi: 10.1164/rccm.201701-0013LE. Am J Respir Crit Care Med. 2017. PMID: 28665681 No abstract available.
-
Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.Am J Respir Crit Care Med. 2017 Dec 1;196(11):1489-1490. doi: 10.1164/rccm.201705-0995LE. Am J Respir Crit Care Med. 2017. PMID: 28715229 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources